Clinical and Demographic Characteristics of 626 Patients with Moderate and Severe Psoriasis

被引:4
|
作者
Rifaioglu, Emine Nur [1 ]
Ozarmagan, Guzin [2 ]
机构
[1] Mustafa Kemal Univ Tayfur Ata Sokmen, Tip Fak, Dermatol Anabilim Dali, TR-31000 Antakya, Hatay, Turkey
[2] Istanbul Univ, Istanbul Tip Fak, Dermatol Anabilim Dali, Istanbul, Turkey
关键词
Psoriasis; Sociodemography; Clinical Features;
D O I
10.4328/JCAM.2413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: In our study, we aim to investigate the demographic, clinic features and the treatments of patients with moderate to severe psoriasis who were followed in outpatient clinic of psoriasis of Department of Dermatology in Istanbul Medical School of Istanbul University. Material and Method: One thousand eight hundred and thirty-one patients, who were followed between 2002-2008 in outpatient clinic of psoriasis. were screened and 626 (34%) of them, who were moderate and severe. were evaluated retrospectively. Results: Three hundred five of the patients who participated in our study were female and 321 were male. Mean age of onset was 28.1. Most frequently clinical type was plaque psoriasis. Most frequently nail involvement was pitting in patients. Nail involvement was statistically common in arthropathic patients. Family history was statistically common in psoriasis patients with early onset Retinoid was the most common used systemic drug. Narrow band UVB was the most common used phototherapy. Discussion: Moderate to severe psoriasis rate was 34%. Female to male ratio was close to one another. Peak age of onset of psoriasis was between 16-25 years old. The most common concomitant systemic disease was diabetes mellitus. The findings were consistent with the literature. Consequently psoriasis is a chronic. recurrent, inflammatory dermatologic disease which affect 2% of the word and which negatively affect the quality of life in patients with comorbidities. Especially in severe forms of psoriasis can cause loss of labor in patients. A good knowledge of demographic and clinical characteristics of psoriasis is important to shedding light on the further clinical studies.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [41] Pharmacokinetic–Pharmacodynamic–Efficacy Analysis of Efalizumab in Patients with Moderate to Severe Psoriasis
    Chee M. Ng
    Amita Joshi
    Russell L. Dedrick
    Marvin R. Garovoy
    Robert J. Bauer
    Pharmaceutical Research, 2005, 22 : 1088 - 1100
  • [42] Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date
    Kivelevitch, Dario
    Amin, Sima
    Menter, Alan
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2019, 12 : 249 - 253
  • [43] On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis
    Puig, L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (02) : 131 - 134
  • [44] Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical Trials
    Mease, Philip J.
    Signorovitch, James
    Yu, Andrew P.
    Wu, Eric Q.
    Gupta, Shiraz R.
    Bao, Yanjun
    Mulani, Parvez M.
    DERMATOLOGY, 2010, 220 (01) : 1 - 7
  • [45] Correlation between clinical severity and quality of life in moderate to severe psoriasis patients: real-world evidence
    Milidrag, Ardea
    Safiye, Teodora
    Gutic, Medo
    Zlatanovic, Milena
    Radevic, Svetlana
    Ravic-Nikolic, Ana
    VOJNOSANITETSKI PREGLED, 2023, 80 (11) : 927 - 932
  • [46] Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis
    Feldman, Steven R.
    Merola, Joseph F.
    Pariser, David M.
    Zhang, Jingchuan
    Zhao, Yang
    Mendelsohn, Alan M.
    Gottlieb, Alice B.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1670 - 1675
  • [47] Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience
    Gonulal, Melis
    Altunay, Ilknur Kivanc
    Dogan, Sinan
    Turkmen, Meltem
    Balci, Didem Didar
    Ozturkcan, Serap
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [48] EMPATHY Life in Psoriasis: Embracing Patients' Well-Being in Their Journey of Moderate-to-Severe Psoriasis
    Prignano, Francesca
    Campione, Elena
    Parodi, Aurora
    Vegni, Elena
    Bardazzi, Federico
    Borroni, Riccardo G.
    Burlando, Martina
    Cinotti, Elisa
    Dini, Valentina
    Giacchetti, Alfredo
    Giofre, Claudia
    Megna, Matteo
    Zichichi, Leonardo
    Fargnoli, Maria Concetta
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [49] Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
    Molina-Leyva, Alejandro
    Almodovar-Real, Ana
    Carrascosa, Jose Carlos-Ruiz
    Molina-Leyva, Ignacio
    Naranjo-Sintes, Ramon
    Jimenez-Moleon, Jose Juan
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2015, 90 (03) : 338 - 345
  • [50] Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses
    Armstrong, April W.
    Edson-Heredia, Emily
    Naegeli, April N.
    Burge, Russel
    Poon, Jiat-Ling
    Anatchkova, Milena
    Sun, Luna
    Zhu, Baojin
    Wyrwich, Kathleen W.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (05) : 452 - 459